JAZMINE WELDY: Open Payments
NPI 1912527474 · SOUTH BEND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 25 payments from 13 companies in 2025. Trend: 2023 $490 · 2024 $897 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $103 |
| Alnylam Pharmaceuticals Inc. | 3 | $84 |
| Novartis Pharmaceuticals Corporation | 3 | $51 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $41 |
| Ethicon US, LLC | 1 | $39 |
| PFIZER INC. | 2 | $32 |
| Abbott Laboratories | 1 | $31 |
| Philips North America LLC | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $19 |
Products named: VERQUVO, ONPATTRO, LifeVest, SURGICEL NU-KNIT, LEQVIO, VYNDAQEL, CARDIOMEMS, IV Other.
Industry payments across IN — which companies pay providers there.
